Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAGIC: Oral N-acetylglucosamine in Crohn's Disease
NCT07225998Phase 2Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of n-acetyl-d-glucosamine in Crohn's disease, sponsored by Johns Hopkins University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
n-acetyl-d-glucosamine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07225998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225998.